3Kawano Y, Matsuoka H, Takishita S, et al. Effects of Magnesium Supplementation in Hypertensive Patients[J]. Hypertension, 1998,32(,2):260-265.
4Laurant P, Hayoz D, Brunner HR, et al. Effect of Magnesium Deficiency on Blood Pressure and Mechanical Properties of Rat Carotid Artery[J] .Hypertension, 1999,33(5) : 1105-1110.
5Woods KL, Fletcher S, Roffe C, et cd. Intravenous magnesium sulphate in suspected acute myocardial infarction:results of the second Leicester Intravenous Magnesium Intervention Trial ( LIMIT-2 ) [ J ]. Lancet,1992,339(8809) : 1553-1558.
6ISIS-4Collaborative Group. ISIS-4:a randomized factorial trial assessing early oral captopfil, oral mononitrate, and intravenous magnesium sulphate in 58 050 patients with suspected acute myocardial infarction[J].Lancet, 1995,345 ( 8951 ) : 669-685.
7Elliott M. Magnesium in Acute MI[J]. Circulation, 1995,92(9 ) : 2367-2372.
8Herzog WR, Schlossberg M, Macmurdy KS, et cd. Timing of Magnesium Therapy Affects Experimental Infarct Size [ J]. Circulation, 1995,92(9) : 2622-2626.
9Bavn H, Moeldrup V, Brookes C, et cd. Intravenous Magnesium Reduces Infarct Size After IsehemiaJReperfusion Injury Combined with a Thrombogenic Lesion in the Left Anterior Descending Artery[ J]. Arterioscler,Thromb Vase Biol, 1999,19(2) :569-574.
10The MAGIC Steering Committee Watertown, Mass. Rationale and design of the magnesium in coronaries( MAGIC )study: A clinical trial to reevaluate the efficacy of early administration of magnesium in acute myocardial infarction[J] .Am Heart J,2000,92(9) : 10-14.
二级参考文献23
1Dyckner T.Relation ofcardiovascular disease to potassium and magnesium defi ciencies.Am J Cardiol,1990,65:44K-46K.
2Teo KK, Yusuf S, Collins R, et al.Effects of intravenous magnesium in suspec t edacute myocardial infarction: overview of randomized trials.BMJ, 1991,303:14 99-1503.
3Woods Kl, Fletcher S, Roffe C, et al.Intravenous magnesium sulphate in suspe c tedacute myocardial infarction: results of the second Leicester intravenous Mag nesiumIntervention Trial (LIMIT-2).Lancet, 1992,339:1553-1558.
4ISIS-4 Collaborative Group.ISIS-4: a randomized factorial trial assessing ear lyoral captoprial, oral mononitrate, and intravenous magnesium sulfate in 58050 patientswith suspected myocardial infarction.Lancet, 1995, 345:669-685.
5The MAGIC Steering Committee Watertown, Mass.Rationale and design of the Mag nesium in Coronaries (MAGIC) study: A clinical trial to reevaluate the efficacy o f earlyadministeation of magnesium in acute myocardial infarction.Am Heart J, 2000,139:10-14.
6Shechter M, Hod H, Kaplinsky E, et al.Magnesium as alternative therapy in pa tients with acute myocardial infarction who are not candidates for thrombolytic t herapy.AmJ Cardiol, 1995,75:321-323.
7Shibata M, Ueshima K, Nakamura M, et al.Effect of magnesium sulfate pretreat m entand significance of mareix metalloproteinase-1 and interleukin-6 levels in c oronaryreperfusion therapy for patients with acute myocardial infarction.Angi ology, 1999,50:573-582.
8Naik P, Malati T, Ratnakar KS, et al.Cardioprotective effect of magnesium c hloridein experimental acute myocardial infarction.Indian J Exp Biol, 1999,37 :131-137.
9Antman EM. Magnesium in acute myocardial infarction: overview of available e vidence. Am Heart J, 1996, 132:487-495.
10Dyckner T, Wester PO. Serum magnesium in acute myocardial infarction relatio n to arrhythmias. Acta Med Scand, 1980, 207:59.
